glp-1 news 2025 october 21 When Joshua Hunt (@viajoshhunt) started Ozempic in April 2025 What's next for GLP-1 innovation:

Yet ResMed still trades at a 36x P/E

This positions GSH as an abundant intermediate carrier that forms a large, exchangeable Cu + pool, buffering copper ions between cellular uptake and delivery to high-affinity protein targets

The main feature that IGF-1 LR3 stands out with is the prolonged effect, the aspect that the rivals cannot boast

Our food dysfunction was never just about the food

This is where the concept of body recomposition truly comes into play, moving beyond the scale to focus on changing your bodys muscle-to-fat ratio

Additionally, because the procedure is not FDA-approved, it is not standardized in the U.S., meaning that techniques and outcomes can vary widely among providers